At EnClear Therapies, we are combining Bioscience & Med-tech expertise to develop solutions that improve and extend the lives of patients with CNS disease.
The team at EnClear is developing systems and medical interventions that Access, Recirculate & Modify CSF for:
› Targeted removal of toxicity from CSF correlated to neurodegenerative disease progression.
› Continuous localized delivery of therapeutics & monitoring of CSF to ensure effective and personalized therapy.
Location: United States, Massachusetts, Newburyport
Employees: 11-50
Total raised: $12M
Founded date: 2018
Investors 6
Date | Name | Website |
- | Dolby Fami... | dolbyventu... |
- | Flucas Ven... | flucasvc.c... |
- | Quark Vent... | quarkventu... |
- | Tachyon Ve... | tachyon.vc |
- | VU Venture... | vuventurep... |
- | Bioverge | ventures.b... |
Funding Rounds 2
Date | Series | Amount | Investors |
21.02.2020 | Series A | $10M | - |
14.03.2019 | Seed | $2M | - |
Mentions in press and media 8
Date | Title | Description | Source |
21.02.2020 | Life Sciences Company EnClear Therapies Raises $10 Million | EnClear Therapies — a life sciences company developing device-based therapies for the treatment of n... | pulse2.com... |
19.02.2020 | EnClear Therapies Raises $10M in Series A Financing | EnClear Therapies, a Cambridge, Mass.-based life sciences company developing device-based therapies ... | finsmes.co... |
19.02.2020 | EnClear Therapies Announces $10M Series A Financing | - | dolbyventu... |
19.02.2020 | Daily funding roundup - February 19th, 2020 | Croquet raised $2.7M; BluBracket closed $6.5M; UltraSense Systems landed $20; Maven picks up $45M C... | vator.tv/n... |
19.02.2020 | EnClear Therapies Announces $10M Series A Financing | CAMBRIDGE, Mass.--(BUSINESS WIRE)--EnClear Therapies, a life sciences company developing device-base... | citybizlis... |
26.08.2019 | Presight Capital raises $80M fund to connect US startups wit... | Presight Capital, the international venture arm of Apeiron Investment Group, is announcing that it’s... | techcrunch... |
25.04.2019 | Enclear Therapies wins novel device challenge | EnClear Therapies’ system designed to treat amyotrophic lateral sclerosis (ALS) and other neurodegen... | massdevice... |
14.03.2019 | EnClear Therapies Raises $2M in Seed Funding | EnClear Therapies, a Cambridge, MA-based biotechnology company developing device-based therapies for... | finsmes.co... |